CytoMatrix Multi-Matrix
Natural health product licensed in Canada
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80091055
- Status
- Active licence
- Licence date
- 5 March 2019
- Revision date
- 10 April 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Molybdène: up to 200 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 76 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Iode: up to 152 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 400 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 180 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 76 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSA for adults (8 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thiamine Source : Chlorhydrate de thiamine | 20 mg | 80,000 µg |
| Molybdène Source : Citrate de molybdène (VI) | 50 mcg | 200 µg |
| Bêta-carotène Source : bêta-carotène Potency : 1,660 UI | 996 mcg | Not calculated |
| Biotine Source : Biotine | 125 mcg | 500 µg |
| Calcium Source : Citrate de calcium | 40 mg | 160,000 µg |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 19 mg | 76,000 µg |
| Iode Source : Iodure de potassium | 38 mcg | 152 µg |
| Magnésium Source : Citrate de magnésium | 20 mg | 80,000 µg |
| Potassium Source : Citrate de potassium | 10 mg | 40,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 30 mcg | 120 µg |
| Zinc Source : Citrate de zinc | 2.5 mg | 10,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 250 UI | 6.25 mcg | 25 µg |
| Mélange de concentré de tocophérol Source : Concentré de tocophérols, mélange | 30 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 100 mg | 400,000 µg |
| Riboflavine Source : Riboflavin 5'-phosphate de sodium | 3.5 mg | 14,000 µg |
| Niacine Source : Acide nicotinique | 5 mg | Not calculated |
| Niacinamide Source : Niacinamide | 15 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 77 mcg | 308 µg |
| Folate Source : L-5-methyltetrahydrofolate | 130 mcg | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 2.25 mg | 9,000 µg |
| Chrome Source : Citrate de chrome(III) | 45 mcg | 180 µg |
| Vanadium Source : Citrate de vanadium | 45.5 mcg | Not calculated |
| Sélénium Source : Sélénométhionine | 50 mcg | 200 µg |
| Choline Source : Dihydrogénocitrate de choline | 10 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
A multi-vitamin/mineral supplement. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. For maintaining general health. Contributes to maintaining general health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80091055
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.